From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006: A study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005: References

From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages)

Table of Contents

Acknowledgments
Acronyms and abbreviations
Foreword
1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
	Introduction
	Methods
	Discussion
	Conclusion
	References
2. Overview of antiretroviral therapy, adherence and drug-resistance
	Background
	References
3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
	Introduction
	Promoting the rational use of drugs
	Promoting Rational Drug Use in the Community course
	Three ARV adherence studies: the process
	How the process was funded
	Discussion and conclusion
	References
	Annex 1: PRDUC course participants by region, type of institution, sex and source of funding
	Annex 2: URLs for country proposals
	Annex 3: Call for proposals
4. There's hope - early observations of ARV treatment roll-out in South Africa
Factors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Research problem
		1.2 Research questions
		1.3 Study objectives
	Chapter 2: Background
		2.1 History of HIV and AIDS in Botswana
		2.2 Botswana's ART programme
		2.3 Literature review
		2.4 Definition of concepts
	Chapter 3: Methodology
		3.1 Introduction
		3.2 Study design
		3.3 Study population
		3.4 Description of study sites
		3.5 Inclusion and exclusion criteria
		3.6 Selection and training of data collectors
		3.7 Qualitative data collection
		3.8 Observations
		3.9 Semi-structured interviews
		3.10 Exit interviews
		3.11 Focus group discussions
		3.12 Quantitative data
		3.13 Data analysis
		3.14 Emic perspective
		3.15 Ethical considerations
		3.16 Feedback
	Chapter 4: Quantitative results
		4.1 Adherence measurement tool results
		4.2 Rates of adherence to ARVs
		4.3 Reasons for skipping medication
		4.4 Factors affecting adherence to ART
		4.5 Predictors of adherence to ART
		4.6 Quantitative results of exit interviews
	Chapter 5: Qualitative results
		5.1 Constraints to adherence to ART
		5.2 Facilitators of adherence to ART
		5.3 Observation of health facilities 5.3.1 Structural issues
		5.4 National level policy issues
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusions
		6.3 Recommendations
	References
	Annex 1: Mean of rates adherence
	Annex 2: Multivariate logistic regression analyses on the predictor variables
	Annex 3: Questionnaires
A study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Rationale
		1.3 Literature review
		1.4 Problem statement
		1.5 Objectives
		1.6 Output
	Chapter 2: Methodology
		2.1 Study design
		2.2 Study population
		2.3 Inclusion and exclusion criteria for interviewees
		2.4 Quantitative data
		2.5 Qualitative data
		2.6 Data collection tools
		2.7 Pilot study
		2.8 Sample size and sampling strategy
		2.9 Data collection
		2.10 Ethics
	Chapter 3: Study areas
		3.1 Health care facilities
	Chapter 4: Quantitative results
		4.1 Demographic characteristics of ARV users
		4.2 Adherence rates
	Chapter 5: Qualitative results
		5.1 Factors that influence adherence to ARVs from the users' perspective
		5.2 Quality of operating structures
		5.3 Opinions and suggestions given by respondents to improve provision of ARVs
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusion
		6.3 Recommendations
		6.4 Proposed interventions
	References
	Annex 1: Exit interview with ARV users
	Annex 2: Semi-structured interview with ARV users
	Annex 3: ARV users, FGDs
	Annex 4: Adherence measurement tools
	Annex 5: Key informant interview
	Annex 6: Semi-structured interviews (with staff)
	Annex 7: Observation (consultations)
	Annex 8: Observation of antiretroviral
Factors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
	Acknowledgements
	Glossary
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Research problem
		1.3 Research objective
	Chapter 2: Background to the study
		2.1 History of AIDS in Uganda
		2.2 History of ARVs in Uganda
	Chapter 3: Literature review
		3.1 Importance of adherence to ART
		3.2 Measurement of adherence
		3.3 Factors affecting adherence to ART
		3.4 Impact of the drug regimen on adherence
		3.5 Treatment characteristics affecting adherence 3.5.1 Physical state and disease stage
		3.6 The clinic setting and service provision
		3.7 Simplifying treatment regimes to improve adherence
		3.8 Conceptual framework
	Chapter 4: Methodology
		4.1 Study design
		4.2 Study population
		4.3 Inclusion and exclusion criteria
		4.4 Sample size and selection
		4.5 Data collector selection and training
		4.6 Pilot testing
		4.7 Data collection
		4.8 Data analysis
		4.9 Evaluation of methods
		4.10 Ethical considerations
	Chapter 5: Description of the study sites
		5.1 Jinja Regional Referral Hospital
		5.2 Nile Treatment Centre
		5.3 Study limitations
	Chapter 6: Results
		6.1 Demographic characteristics of ARV users
		6.2 Factors influencing adherence to ART
	Chapter 7: Discussion, conclusions and recommendations
		7.1 Discussion
		7.2 Conclusions
		7.3 Recommendations
	References
Back cover

References

1. Akam AW et al. (2004). Anti-retroviral adherence in a resource poor setting. International Conference on AIDS, 11-16 July 2004.15. Abstract no. B12311.

2. Bangsberg DR et al. (2000). Adherence to protease inhibitor, HIV-1 viral load and development of drug resistance in an indigenous population. A/DS;14:357-366.

3. Carrieri P, Caillefon V, Le moing V. (2001). The dyanamic of adherence to Highly Active Antiretroviral Therapy: Results from the French National APROCO cohort. Journal of Acquired Immune Deficiency Syndromes, 28:232-239.

4. Chesney MA (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(Suppl 2):S171-S176.

5. CIA. The world factbook 2003, (Tanzania). Available at: http:/www.cia.gov/cia/publications/factbook/geos/tz.html.

6. DiMatteo MR (2004). Variations in patients' adherence to medical recommendations. A quantitative review of 50 years of research. Medical Care, 42:200-209.

7. Eldred IJ, Wu Aw, Chaisson RE (1998). Adherence to antiretroviral and pneoumcystic prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes, 18:117.

8. Garcia R, Schooley, R, Badaro R (2003). An adherence triology is essential for long term HAART success. Brazilian Journal of Infectious Diseases, 7(5): 1-9.

9. Horne R, Buick D, Fischer M (2001). Perceptions of HIV and HAART as barriers to adherence. 5^th AIDS Impact, Brighton, UK, 2001. Abstract no.105. 2002; 28:232-9.

10. Horne R. Compliance, adherence and concordance. In: Taylor K, Harding G, eds. Pharmacy practice. London, Taylor & Frances, 2001:165-184.

11. Horne R. Adherence to medication, a review of existing research. In: Myers L, Midence K, eds. Adherence to treatment in medical conditions. London, Harwood Academic, 1998:285-310.

12. Lerner BH, Gulick RM, Dubler NN. Rethinking non-adherence:historical perspectives on triple-drug therapy for HIV disease. Annals of Internal Medicine, 1998,129(7):573-578.

13. Ison CA, Dillon JA, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria Gonorrhoeae and Haemophilus ducreyi. Lance, 1998:351(Suppl 3):8-ll.

14. Massele AY et al. (1993). Knowledge and management of malaria in Dar es Salaam, Tanzania. East African Medical Journal, 70(10):639-42.

15. Massele AY, Ofori-Adjei D, Laing RO. (1993). A study of prescribing patterns with special reference to drug use indicators in Dar es Salaam Region, Tanzania. Tropical Doctor, 23(3):104-7.

16. Mhalu F. The impact of globalization on spread of emerging and re-merging diseases. Keynote address to NIMR's 19^th Annual Joint Scientific Conference AICC, 15-17 March 2004.

17. Ministry of Health. National guidelines for malaria diagnosis and treatment. (2000). Malaria Control Series 1. Dar es Salaam, Ministry of Health of the United Republic of Tanzania, 2000.

18. Ministry of Health. Report of the baseline survey of the pharmaceutical sector in Tanzania. Dar es Salaam, Ministry of Health of the United Republic of Tanzania and World Health Organization, 2002:22-23.

19. Mnyika KS, Killewo JZ, Kabalimu TK. Self-medication with antimalarial drugs in Dar es Salaam, Tanzania. Trop Geogr.Med. 1995;47(l):32-4.

20. Murphy DA, Wilson CM, Durako SJ (2001). Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care,13,(1) 27-40.20.

21. NACP(2003). HIV/AIDS/STI Surveillance Report, No.17.

22. National Bureau of Statistics-United Republic of Tanzania (2003). National population and housing census general report 2002. Dar es Salaam, Central Census Office, National Bureau of Statistics, President's Office Planning and Privatisation, Tanzania.

23. Parades R (2000). Predictors of virology success and ensuing failure in HIV positive patients starting HAART in Europe. Archives of Internal Medicine. 160:1123-1132.

24. Rabkin M, El- Sadr W, Abrahams E (2003). MTCT-Plus clinical manual. Mailman School of Public Health, Columbia University, USA. Available at: http://www.mtctplus.org/intranet/pdf/ad treatment.pdf

25. Simonen M (2003). Population and Development Perspective, No. 9.

26. Singh N, Squier C, Sirek C (1996). Determinants of compliance with antiretroviral therapy in patients with HIV: prospective assessment with implications for enhancing compliance. AIDS Care, 8:281.

27. Tanzania Food and Drugs Authority. List of registered drugs, 2004. Available at: http://www.tfda.or.tz.

28. Tuldra A, Fumaz C R, Ferrer M J (2000). Prospective randomized two arm controlled study to determine the efficacy of a specific intervention to improve long term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 25; 221-8.

29. UNAIDS 2004. Report on the global AIDS epidemic. Available at: http:/www.unadis.org/bangkok2004/GAR2004 html.

30. UNAIDS 2004. Report on the global AIDS epidemic. Executive summary. Available at: http://www.Unaids.org/bangkok2004/GAR2004 html/ExecSummary en/ExecSumm en 04.htm#P225 26561 accessed on 11/8/2004.

31. United Republic of Tanzania. HIV/AIDS care and treatment plan 2003-2008. (Draft document).

32. Weiser S et al. (2003). Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Defiiency Syndromes, 34:281-288.